BSX achieves CE Mark approval for the ACURATE Prime Aortic Valve System, its latest TAVR technology.…
Boston Scientific (BSX) withdraws its premerger notification and report form to give the U.S. FTC more time to review the…
ServiceNow (NOW), Boston Scientific (BSX) and The Cooper Companies (COO) have been selected as the top picks with a high…
Amazon, Boston Scientific, Shopify and Cooper-Standard are included in this Analyst Blog.…
Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to ones portfolio. Wall Street analysts overly…
Boston Scientifics (BSX) Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of GI and…
Boston Scientific (BSX) registers a strong year-over-year improvement in sales, indicating solid market share gains in legacy businesses across all…
In EMEA, Boston Scientific (BSX) is successfully expanding its base, banking on its diverse portfolio, new launches and commercial execution…
…
In EMEA, Boston Scientific (BSX) is expected to have registered growth within structural heart, including Transcatheter aortic valve replacement, WATCHMAN…
Boston Scientific (BSX) secures CE Mark for the DBS image-guided programming software, Vercise Neural Navigator 5.…
Boston Scientific, ResMed, Lantheus and Haemonetics are part of the Zacks Industry Outlook article.…
…
This acquisition is expected to enhance Boston Scientifics (BSX) market position and revenue streams in North America and Europe.…
Silk Road Medical to be acquired by Boston Scientific, shares surge 24%…
…
Boston Scientific to buy Silk Road Medical in $1.16 billion deal…
Boston Scientific to acquire Silk Road Medical for $27.50 per share in cash…
…
Der Kurs der der Aktie von Boston Scientific kommt kaum von der Stelle. Das Wertpapier kostete zuletzt 74,83 US-Dollar. Kaum…
Investors continue to be optimistic about Boston Scientific (BSX) due to its geographical expansions and impressive acquisitions.…
Boston Scientifics (BSX) Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of GI and…
Investors are optimistic about Boston Scientifics (BSX) impressive market share gain in the MedSurg segment and continued geographical expansion.…
Boston Scientific (BSX) mCRM System is designed to communicate wirelessly and coordinate painless intracardiac anti-tachycardia pacing (ATP) therapy.…
…
Within Neuromodulation, Boston Scientifics pain business is consistently gaining traction, banking on strength in the spinal cord stimulation (SCS) business.…
Todays Research Daily features new research reports on 16 major stocks, including Boston Scientific Corporation (BSX), Arista Networks, Inc. (ANET)…
Cardiovascular diseases remain the leading global cause of death, taking an estimated 17.9 million lives annually, based on data from…
Boston Scientific pipeline strength fuels quarterly earnings beat…
Barring Neuromodulation, organic and operational revenues at Boston Scientifics (BSX) core business segments rise in the first quarter.…
…
New York (www.aktiencheck.de) - Stryker-Aktienanalyse von Evercore ISI:
Die Analysten von Evercore ISI stufen die Aktie von Stryker Corp. (ISIN: US8636671013,…
Boston Scientific (BSX) is expected to have registered strong growth in the Asia Pacific, led by strength in China, Japan…
CODE Der jüngste Kurs betrug 68,40 US-Dollar. Kaum verändert im Vergleich zu der Schlussnotierung vom Vortag zeigt sich derzeit der…
With Boston Scientific (BSX) recording 40% of its sales from the international market, it remains highly exposed to currency fluctuations.…
Passive investing in index funds can generate returns that roughly match the overall market. But in our experience...…
…
Boston Scientific merger with Axonics faces FTC scrutiny…
…
Boston Scientific EVP Wendy Carruthers sells $477,776 in stock…
…
Boston Scientific (BSX) and Scivita Medical announce an expanded strategic cooperation arrangement.…
Scivita Medical broadens ties with Boston Scientific…
Boston Scientific (BSX) is consistently registering fast recovery within its MedSurg segment in the post-pandemic period.…
…
The AGENT DCB of Boston Scientific (BSX) is already available in Europe, parts of Asia Pacific and Latin America.…
Boston Scientific completes €2 billion senior notes offering…
Boston Scientific (BSX) is benefitting from an impressive gain in MedSurg market share and the strong adoption of WATCHMAN FLX.…
Boston Scientific (BSX) announces the completion of its first commercial cases with its FDA-cleared Farapulse PFA System in the United…
Investors are optimistic about Boston Scientific (BSX) on strength across the target market and upbeat guidance.…